Expressions of circadian clock genes represent disease activities of RA patients treated with biological DMARDs.
Kaneshiro K, Yoshida K, Morii K, Oketani Y, Uchida K, Yaekura A, Okumura I, Hashimoto T, Kawasaki Y, Shibanuma N, Sakai Y, Hashiramoto A.
Kaneshiro K, et al. Among authors: morii k.
Mod Rheumatol. 2020 Mar;30(2):293-300. doi: 10.1080/14397595.2019.1602242. Epub 2019 May 2.
Mod Rheumatol. 2020.
PMID: 30942638
Free article.